Part 2 - Examining the Implications of Clinical Pathways on the Oncology Marketplace

TKG PACT Executive Briefings - 3-Minute Market Insights

English - March 22, 2021 04:00 - 25 minutes - 17.7 MB - ★★★★★ - 2 ratings
Medicine Health & Fitness healthcare pharma voice triple aim biotech health management insights Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Part 1 - Examining the Implications of Clinical Pathways on the Oncology Marketplace

Next Episode: Part 1 - Dr. Marty Heslin talks about the "New Normal" for cancer care

Part 2 - Examining the Implications of Clinical Pathways on the Oncology Marketplace

In Part 1 of this conversation, Ron talked about the increasing use of clinical treatment pathways by payers and providers to influence formulary decision making. In Part 2, we continue this discussion with Ron sharing his insights coming from their firm’s syndicated reports, as well as his thoughts on how life science companies should be training their field teams to be navigating these complex issues.
Ron Schleif can be reached at [email protected]